Old Web
English
Sign In
Acemap
>
Paper
>
41O Nine weeks vs 1-year adjuvant trastuzumab: Long term outcomes of the ShortHER randomised trial
41O Nine weeks vs 1-year adjuvant trastuzumab: Long term outcomes of the ShortHER randomised trial
2021
Pierfranco Conte
Antonio Frassoldati
Giancarlo Bisagni
Alba A. Brandes
Michela Donadio
Ornella Garrone
Federico Piacentini
L. Cavanna
Francesco Giotta
Michele Aieta
V. Gebbia
A. Musolino
Antonella Ferro
S. Danese
Claudio Zamagni
Oriana Nanni
Maria Vittoria Dieci
R. Vicini
Sara Balduzzi
Valentina Guarneri
Keywords:
Trastuzumab
Internal medicine
Adjuvant
long term outcomes
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]